Canaccord Genuity Maintains Buy on Blend Labs, Lowers Price Target to $4.5
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Joseph Vafi maintains Blend Labs (NYSE:BLND) with a Buy and lowers the price target from $5.25 to $4.5.
Canaccord Genuity analyst Joseph Vafi maintains Blend Labs (NYSE:BLND) with a Buy and lowers the price target from $5.25 to $4.5.